Targeting Pyruvate Kinase M2 As a Novel Therapeutic Strategy Against Liver Fibrosis and Hepatocellular Carcinoma

被引：0

作者：

Zheng, Dandan ^{[1
]}

Lin, Zelong ^{[1
,2
]}

Hu, Kaishun ^{[3
]}

Lan, Tian ^{[4
]}

Holmes, Jacinta A. ^{[5
,6
,7
]}

Song, Zhenghui ^{[2
,8
]}

He, Lu ^{[1
]}

Jiang, Yuchuan ^{[1
]}

Chen, Peng ^{[1
,2
]}

Tu, Mengxian ^{[1
]}

Chen, Hengxing ^{[3
]}

Hu, Qiaoting ^{[1
]}

Qu, Chen ^{[1
,2
]}

Lin, Wenyu ^{[5
,6
,7
]}

Li, Aimin ^{[2
,8
]}

Chung, Raymond T. ^{[5
,6
,7
]}

Hong, Jian ^{[1
,2
]}

机构：

[1] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China

[2] Southern Med Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China

[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China

[4] Guangdong Pharmaceut Univ, Guangzhou, Guangdong, Peoples R China

[5] Massachusetts Gen Hosp, Liver Ctr, Boston, MA 02114 USA

[6] Massachusetts Gen Hosp, Gastrointestinal Div, Boston, MA 02114 USA

[7] Harvard Med Sch, Boston, MA USA

[8] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Dept Hepatol, Guangzhou, Guangdong, Peoples R China

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1120

引用

页码：646A / 647A

页数：2

共 50 条

[21] Pyruvate kinase M2 at a glance
Yang, Weiwei
Lu, Zhimin
JOURNAL OF CELL SCIENCE, 2015, 128 (09) : 1655 - 1660
[22] Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma
Yu Akazawa
Toshihiro Suzuki
Toshiaki Yoshikawa
Shoichi Mizuno
Yasunari Nakamoto
Tetsuya Nakatsura
World Journal of Meta-Analysis, 2019, 7 (03) : 80 - 95
[23] Selective Covalent Targeting of Pyruvate Kinase M2 Using Arsenous Warheads
Wang, Jingyao
Zhou, Shaoqing
Cheng, Yan
Cheng, Lin
Qin, Ying
Zhang, Zhenfeng
Bi, Aiwei
Xiang, Huaijiang
He, Xinheng
Tian, Xiaoxu
Liu, Wenbin
Zhang, Jian
Peng, Chao
Zhu, Zhengjiang
Huang, Min
Li, Ying
Zhuang, Guanglei
Tan, Li
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (04) : 2608 - 2621
[24] Search progress of pyruvate kinase M2 (PKM2) in organ fibrosis
Lv, Shumei
Cao, Mengfei
Luo, Jie
Fu, Kewei
Yuan, Wei
MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
[25] Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2
Babu, Mani Shankar
Mahanta, Sailendra
Lakhter, Alexander J.
Hato, Takashi
Paul, Subhankar
Naidu, Samisubbu R.
PLOS ONE, 2018, 13 (02):
[26] SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma
Tai, Wei-Tien
Hung, Man-Hsin
Chu, Pei-Yi
Chen, Yao-Li
Chen, Li-Ju
Tsai, Ming-Hsien
Chen, Min-Husan
Shiau, Chung-Wai
Boo, Yin-Pin
Chen, Kuen-Feng
ONCOTARGET, 2016, 7 (16) : 22193 - 22205
[27] Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes
Apostolidi, Maria
Vathiotis, Ioannis A.
Muthusamy, Viswanathan
Gaule, Patricia
Gassaway, Brandon M.
Rimm, David L.
Rinehart, Jesse
CANCER RESEARCH, 2021, 81 (16) : 4346 - 4359
[28] Targeting of the glycolytic keyregulator pyruvate kinase subtype M2 by peptide aptamers
Spoden, G
Mazurek, S
Morandell, D
Eigenbrodt, E
Zwerschke, W
INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 : S5 - S5
[29] Targeting RFX-1 as a novel therapeutic strategy in hepatocellular carcinoma
Su, Jung-Chen
CANCER RESEARCH, 2015, 75
[30] Pyruvate Kinase M2: A Novel Regulator of Brown and Fat Adipogenesis
Knoxville, Presley Dowker
OBESITY, 2021, 29 : 149 - 149

← 1 2 3 4 5 →